CLINIC-LABORATORY INDICATORS OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA
Abstract
Chronic myelogenous leukemia (CML) is a form of leukemia that is caused by damage to myeloid tissue. This disease is characterized by excessive proliferation and unregulated growth of mainly myeloid cells in the bone marrow and their accumulation in the blood. Chronic myelogenous leukemia (CML) accounts for about 20% of all leukemias. Chronic myelogenous leukemia (CML) occurs in all age groups, half of the patients are in the age group of 30-50 years.
References
V. _ G. _ Savchenko . Klinicheskie recommendation po diagnostics i Lecheniyu chronicheskogo myeloid leukemia / Abdulkadyrov K. _ M. , Turkina A. _ G. , Zaritsky A. _ Yu ., Lomaia E. _ G. , Chelysheva E. _ Yu ., Vinogradova O. _ Yu ., Gusarova G. _ A. , Shuvaev V. _ A. , Martynkevich I. _ S. , Domracheva E. _ V. , Lazareva O. _ V. , Shukhov O. _ A. , Kuznetsov S. _ V. _ - 2014
Vorobev A.I. Abdulkadyrov K.M., Khoroshko N.D./Diagnosis and therapy of chronic myeloid leukemia . - 2011, Moscow. 53 p
Vorobeva A. I. Rukovodstvo po hematologii : v 3 t. T. 1 / A. I. Vorobeva. — M. : Newdiamed ; 2002.
